Posted by Michael Wonder on 20 Jan 2021
Is Novavax the dark horse of Australia's COVID-19 vaccines?
19 January 2021 - Experts say early clinical data on Australia's third COVID-19 vaccine, Novavax, is promising enough to suggest it could play a significant role in the nation's pandemic strategy.
The federal government has signed up to buy 51 million doses of Novavax’s two shot vaccine and those involved in trials say it is expected to be made available as early as the middle of this year, in addition to COVID-19 vaccines from Pfizer and AstraZeneca that will be available in coming weeks.
